# Early Administration of Long-acting Insulin Treatment of Diabetic Ketoacidosis in Pediatric Type 1 Diabetes

> **NCT02548494** · NA · TERMINATED · sponsor: **Chattanooga-Hamilton County Hospital Authority** · enrollment: 17 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1
- Diabetic Ketoacidosis

## Interventions

- **DRUG:** Glargine
- **DRUG:** IV insulin
- **OTHER:** Electrolyte Correction
- **OTHER:** Correction of Fluid Loss

## Key facts

- **NCT ID:** NCT02548494
- **Lead sponsor:** Chattanooga-Hamilton County Hospital Authority
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-11
- **Primary completion:** 2019-02-01
- **Final completion:** 2019-02-01
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Project terminated due to insufficient resources for recruitment.
- **Last updated:** 2020-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02548494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02548494, "Early Administration of Long-acting Insulin Treatment of Diabetic Ketoacidosis in Pediatric Type 1 Diabetes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02548494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*